Sesen Bio, Inc. Uncategorized Contracts & Agreements
18 Contracts & Agreements
- Amended and Restated Open Market Sale AgreementSM, dated as of May 12, 2023, by and between the Company and Jefferies LLC (Filed With SEC on May 12, 2023)
- Contingent Value Rights Agreement, dated March 7, 2023 (Filed With SEC on March 8, 2023)
- Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 28, 2022)
- Amendment No (Filed With SEC on June 1, 2021)
- Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 15, 2021)
- Amendment No. 2 to the Open Market Sale Agreement (Filed With SEC on February 17, 2021)
- Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 16, 2020)
- Open Market Sale AgreementSM, dated November 29, 2019, by and between Sesen Bio, Inc. and Jefferies LLC (Filed With SEC on November 29, 2019)
- Placement Agent Agreement, dated as of March 21, 2018 by and between Eleven Biotherapeutics, Inc. and Laidlaw & Company (UK) Ltd (Filed With SEC on March 23, 2018)
- - 2 - (Filed With SEC on September 21, 2016)
- - 2 - (Filed With SEC on September 21, 2016)
- ALMAD INVESTMENTS LIMITED (hereinafter called the Landlord), (Filed With SEC on September 21, 2016)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on August 12, 2016)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on March 25, 2016)
- ELEVEN BIOTHERAPEUTICS, INC. (A corporation existing under the laws of the State of Delaware) (Filed With SEC on December 1, 2014)
- Eleven Biotherapeutics, Inc. (Filed With SEC on January 23, 2014)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on December 30, 2013)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on December 30, 2013)
